CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hellmann, Matthew David
  • Gettinger, Scott N
  • Goldman, Jonathan Wade
  • Brahmer, Julie R
  • Borghaei, Hossein
  • Chow, Laura Q
  • Ready, Neal
  • Gerber, David E
  • Juergens, Rosalyn
  • Shepherd, Frances A
  • Laurie, Scott Andrew
  • Zhou, Ye
  • Geese, William J
  • Agrawal, Shruti
  • Li, Xuemei
  • Antonia, Scott Joseph

publication date

  • May 20, 2016